|
|
 |
Research Activities
- Projects to sequence the whole or partial genomes of a variety of pathogenic microbes. These projects should help scientists understand how the organisms cause disease and identify new drugs and vaccines.
- A broad malaria research program. This program is conducted by scientists at institutions throughout the United States and in several countries where malaria is endemic, and by scientists working in NIAID laboratories. NIAID and other parts of NIH also participate in the Multilateral Initiative on Malaria, a global group that boosts international collaboration among malaria scientists and identifies resources to enhance malaria research.
- Research on the basic biology of influenza viruses and on efforts to find more effective vaccines and treatments for influenza.
- Clinical trials involving several experimental HIV vaccines. NIAID scientists and grantees have conducted trials on more than 52 vaccine candidates since 1987. In 1999, NIAID began the first HIV vaccine trial in Africa, an important step for developing global vaccines. Trials are underway in countries on five continents, reflecting the global nature of this disease. The HIV Vaccine Trials Network, supported by NIAID, is a network of domestic and international clinical research institutions that conducts all phases of vaccine clinical trials.
- Three research groups to learn more about emerging viruses. By learning how these viruses work, researchers hope to develop better ways to diagnose and treat the diseases they cause.
- Research on the pathogenesis of bacterial and viral sexually transmitted infections and prevention strategies to control these infections.
- Institute researchers work closely with other agencies, institutions, and scientists from across the United States and around the world to achieve the common goal of controlling and eliminating infectious diseases.
back to top |
|
|
|